Literature DB >> 26133817

[Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].

Rongqi Wang1, Weiguang Ren, Suxian Zhao, Xuemin Niu, Pufang Tan, Huijuan Du, Yuemin Nan.   

Abstract

OBJECTIVE: To explore the clinical application and related factors of FibroTouch in the diagnosis of liver fibrosis in patients with chronic liver disease through comparison of the specificity and sensitivity of FibroTouch and multi-parameter models, and to identify whether FibroTouch is a more accurate and safe method in diagnosis of liver fibrosis and evaluation of the therapeutic effect.
METHODS: A total of 190 patients with chronic liver disease were performed liver biopsy and underwent liver stiffness measurement (LSM) using FibroTouch in department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University from January 2014 to February 2015. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) were tested by enzymic method with automatic biochemistry analyzer. Blood platelet counts were detected by automatic blood cell analyzer. AST-to-PLT ratio index (APRI) and fibrosis index based on the 4 factor (FIB-4) were calculated. The diagnostic values of FibroTouch, APRI and FIB-4 for liver fibrosis degree were calculated and compared by receiver operating characteristic (ROC) curves. The related factors of LSM were analyzed by Spearman analysis.
RESULTS: There was significant correlation between LSM and histological fibrosis (r=0.804, P=0.000). The area under ROC curve of LSM for S(≥2, S≥3 and S=4 was 0.894, 0.938 and 0.961, respectively, which was significantly higher than APRI (0.678, 0.698 and 0.658) and FIB-4 (0.765, 0.785 and 0.775). On Spearman analysis, LSM was positively correlated with age, ALT, AST, TBIL ((≥2×ULN) and the grade of liver inflammation (r=0.309, 0.558, 0.504, 0.492 and 0.532, respectively) but negatively with PLT (r=-0.444), (all P<0.05).
CONCLUSIONS: LSM is a convenient and reliable approach for diagnosis of liver fibrosis in patients with chronic liver disease. The sensitivity and specificity of Fibrotouch in diagnosis of hepatic fibrosis is superior to APRI and FIB-4, and age, high level ofALT, AST and TBIL (≥2×ULN) were independent predictors of LSM inaccuracy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26133817     DOI: 10.3760/cma.j.issn.1007-3418.2015.04.007

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  4 in total

1.  Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.

Authors:  Lingdi Liu; Zaid Al-Dhamin; Xiwei Yuan; Luyao Cui; Yang Yang; Wen Zhao; Ying Zhang; Na Fu; Yuemin Nan
Journal:  Histol Histopathol       Date:  2020-10-14       Impact factor: 2.303

2.  Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.

Authors:  Xuebin Peng; Aiping Tian; Junfeng Li; Yongwu Mao; Ni Jiang; Ting Li; Xiaorong Mao
Journal:  Dig Dis Sci       Date:  2021-05-31       Impact factor: 3.487

3.  Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients.

Authors:  Hong Deng; Chun-Ling Wang; Jing Lai; Su-Lin Yu; Dong-Ying Xie; Zhi-Liang Gao
Journal:  Hepat Mon       Date:  2016-07-24       Impact factor: 0.660

4.  A statistical analysis of the correlations among various types of clinical indexes for patients with chronic hepatitis B: A hospital-based study.

Authors:  Jie Wang; Yonglan Pu; Yinhua Gong; Zhonghua Li; Xiaofang Zhu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.